HIP-55 negatively regulates myocardial contractility at the single-cell level

Rui Xing1, Shanshan Li2, Kai Liu2

  • 1Institute of Vascular Medicine, Peking University Third Hospital, Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Ministry of Health, Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education and Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.

Insights

HIP-55, an actin binding protein, was found to negatively regulate myocardial contractility in heart cells. Reducing HIP-55 levels enhanced cardiomyocyte contractility, suggesting a new therapeutic target for cardiovascular disease.

Area of Science:

  • Cardiovascular Biology
  • Cellular Mechanics
  • Molecular Cardiology

Background:

  • Myocardial contractility is vital for cardiac output but its regulatory mechanisms are not fully understood.
  • Actin binding proteins play key roles in cellular function, including muscle contraction.

Purpose of the Study:

  • To investigate the role of HIP-55, an actin binding protein, in regulating myocardial contractility at the single-cell level.
  • To elucidate the molecular mechanisms by which HIP-55 influences cardiac function.

Main Methods:

  • Adenovirus-mediated overexpression and knockdown of HIP-55 in cardiomyocytes.
  • Measurement of cardiomyocyte contractility using cell traction force microscopy.
  • Co-localization studies of HIP-55 and F-actin within cardiomyocytes.

Main Results:

  • HIP-55 knockdown significantly increased cardiomyocyte contractility.
  • HIP-55 overexpression reversed the enhanced contractility observed in knockdown cells.
  • HIP-55 was found to co-localize with F-actin in cardiomyocytes, indicating a potential interaction.

Conclusions:

  • HIP-55 negatively regulates myocardial contractility by interacting with F-actin.
  • This study reveals a novel regulatory mechanism for cardiac contractile function.
  • HIP-55 represents a potential therapeutic target for cardiovascular diseases.